ALPS Advisors’s Larimar Therapeutics LRMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-47,460
Closed -$102K 1044
2025
Q1
$102K Sell
47,460
-4,130
-8% -$13.1K ﹤0.01% 979
2024
Q4
$200K Buy
+51,590
New +$341K ﹤0.01% 972
2016
Q4
Sell
-2,903
Closed -$115K 722
2016
Q3
$115K Sell
2,903
-290
-9% -$13.2K ﹤0.01% 668
2016
Q2
$229K Buy
3,193
+641
+25% +$50.7K ﹤0.01% 596
2016
Q1
$205K Sell
2,552
-438
-15% -$34.6K ﹤0.01% 603
2015
Q4
$226K Sell
2,990
-545
-15% -$87.5K ﹤0.01% 669
2015
Q3
$13.6K Buy
3,535
+1,312
+59% +$592K 0.01% 196
2015
Q2
$924K Buy
2,223
+1,139
+105% +$477K 0.01% 216
2015
Q1
$515K Buy
+1,084
New +$515K ﹤0.01% 507

Other funds holding LRMR